Medicine Research news
McGill University’s board of governors has adopted a resolution demanding the Quebec government withdraw the cuts it is imposing on universities and restore the funding that was in place, saying the government’s action is “excessive and injurious” to the university.
Prescription medications remain one of the most common causes of severe adverse reactions in clinical medicine, accounting for thousands of deaths annually in Canada. The urgent need for rigorous, scientific drug safety research has been clearly understood for decades, but lacked national coordination until the arrival of the Canadian Network for Observational Drug Effect Studies (CNODES), which today released its first report documenting progress towards its goal of creating a fully operational system for rapid assessment of adverse drug effects in Canada.
"Despite high per-capita spending, health care in Canada consistently underperforms, according to the Commonwealth Fund, which tracks indicators for accessibility, timeliness and outcomes across a number of developed countries. The system that is straining to meet demand today will face an even higher burden in the years ahead, as the population ages. A number of Canadian business schools are looking to meet this challenge by educating future health care managers to bring new perspectives to old problems.
We’ve known for a while that the vestibular system in the inner ear is responsible for helping us keep our balance. And while researchers have already developed a basic understanding of how the brain constructs our perceptions of ourselves in motion, until now no one has understood the crucial step by which the neurons in the brain select the information needed to do so.
People who suffer from fibromyalgia (FM) – a medical disorder characterized by chronic widespread pain – are turning to the streets for marijuana to relieve their pain.A new study published in the journal Arthritis Care & Research, led by Dr. Mary-Ann Fitzcharles,suggests that These people tend to have poorer mental health, and are often on additional prescribed medications that could result in ne
Cachexia, a syndrome characterized by rapid weight loss and muscle deterioration, is a major cause of death among patients suffering from diseases like cancer, AIDS and chronic infection. Now, a newly published study by McGill University researchers shows that a low dose of Pateamine A is effective at preventing cancer-induced muscle wasting, which may lead to cachexia-fighting drugs.
Whether it is for research into clean energy sources, the future of wireless communication or a better understanding of the processes involved in language learning, over 160 established McGill researchers and more than 80 graduate students will benefit from support from the Natural Sciences and Engineering Research Council of Canada (NSERC) over the next five years.
Thanks to the Cole Foundation, pediatric leukemia research has again this year received support to recruit some of the best and brightest researchers in the field.
According to a new study led by the Research Institute of the McGill University Health Centre (RI MUHC), older women who have been diagnosed with an irregular heartbeat are at higher risk of stroke than men.
Current research ethics focuses on protecting study participants, but according to bioethicists from McGill University and Carnegie Mellon University, these efforts fail to prevent harms that undermine the social value of research.
In a paper published this week in The Journal of Neuroscience, researchers from McGill University have demonstrated for the first time that there are specific neurons that respond selectively to first and second order sensory attributes.
A new McGill University study evaluating off-label prescribing of medications by primary care physicians in Quebec suggests the practice is common, although it varies by medication, patient and physician characteristics. The paper was published online today in the Archives of Internal Medicine.
Nearly one in five people suffers from the insidious and often devastating problem of chronic pain. That the problem persists, and is growing, is striking given the many breakthroughs in understanding the basic biology of pain over the past two decades. Research published online in Nature Medicine points to potential solutions.
A recent study led by Gergely Lukacs, a professor at McGill University’s Faculty of Medicine, Dept. of Physiology, and published in the January issue of Cell, has shown that restoring normal function to the mutant gene product responsible for cystic fibrosis requires correcting two distinct structural defects. This finding could point to more effective therapeutic strategies for CF in the future.